AAAAAA

   
Results: 1-10 |
Results: 10
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study
Authors: Papakostas, P Kouroussis, C Androulakis, N Samelis, G Aravantinos, G Kalbakis, K Sarra, E Souglakos, J Kakolyris, S Georgoulias, V
Citation: P. Papakostas et al., First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study, EUR J CANC, 37(15), 2001, pp. 1833-1838
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study
Authors: Alexopoulos, A Kouroussis, C Malamos, N Kakolyris, S Kalbakis, K Kosmas, C Mavroudis, D Agelaki, S Vlachonicolis, J Sarra, E Rigatos, G Georgoulias, V
Citation: A. Alexopoulos et al., Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study, ANN ONCOL, 12(6), 2001, pp. 793-798
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors
Authors: Kouroussis, C Kakolyris, S Mavroudis, D Androulakis, N Kalbakis, K Agelaki, S Sarra, E Souglakos, J Christodoulakis, M Samonis, G Georgoulias, V
Citation: C. Kouroussis et al., A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors, AM J CL ONC, 24(4), 2001, pp. 404-407
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study
Authors: Kakolyris, S Papadakis, E Tsiafaki, X Kalofonos, C Rapti, A Toubis, M Bania, E Kouroussis, C Chainis, K Androulakis, N Agelaki, S Sarra, E Vardakis, N Georgoulias, V
Citation: S. Kakolyris et al., Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study, LUNG CANC, 32(2), 2001, pp. 179-187
Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: Two parallel multicenter phase II trials
Authors: Agelaki, S Bania, H Kouroussis, C Blazoyiannakis, G Sougalkos, J Tsiafaki, X Harpidou, A Kalbakis, K Rapti, A Androulakis, N Sarra, E Georgoulias, V Papadakis, E
Citation: S. Agelaki et al., Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: Two parallel multicenter phase II trials, ONCOL-BASEL, 60(3), 2001, pp. 235-241
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study
Authors: Giannakakis, T Ziras, N Kakolyris, S Mavroudis, D Androulakis, N Agelaki, S Parashos, M Sarra, E Dimou, T Hatzidaki, D Vlachonikolis, J Georgoulias, V
Citation: T. Giannakakis et al., Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study, EUR J CANC, 36(6), 2000, pp. 742-747
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial
Authors: Mavroudis, D Kourousis, C Androulakis, N Kalbakis, K Agelaki, S Kakolyris, S Souglakos, J Sarra, E Vardakis, N Hatzidaki, D Sarmonis, G Georgoulias, V
Citation: D. Mavroudis et al., Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF) - A phase II trial, AM J CL ONC, 23(4), 2000, pp. 341-344
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy
Authors: Kakolyris, S Souglakos, J Agelaki, S Kourousis, C Mavroudis, D Sarra, E Malliotakis, P Georgoulias, V
Citation: S. Kakolyris et al., A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy, LUNG CANC, 30(3), 2000, pp. 193-198
Docetaxel-induced lymphopenia in patients with solid tumors - A prospective phenotypic analysis
Authors: Kotsakis, A Sarra, E Peraki, M Koukourakis, M Apostolaki, S Souglakos, J Mavromanomakis, E Vlachonikolis, J Georgoulias, V
Citation: A. Kotsakis et al., Docetaxel-induced lymphopenia in patients with solid tumors - A prospective phenotypic analysis, CANCER, 89(6), 2000, pp. 1380-1386
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
Authors: Mavroudis, D Malamos, N Alexopoulos, A Kourousis, C Agelaki, S Sarra, E Potamianou, A Kosmas, C Rigatos, G Giannakakis, T Kalbakis, K Apostolaki, F Vlachonicolis, J Kakolyris, S Samonis, G Georgoulias, V
Citation: D. Mavroudis et al., Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial, ANN ONCOL, 10(2), 1999, pp. 211-215
Risultati: 1-10 |